alexa Antimicrobial Properties of Various Non-Antibiotic Drugs against Microorganisms | Open Access Journals
ISSN: 1948-593X
Journal of Bioanalysis & Biomedicine
Like us on:
Make the best use of Scientific Research and information from our 700+ peer reviewed, Open Access Journals that operates with the help of 50,000+ Editorial Board Members and esteemed reviewers and 1000+ Scientific associations in Medical, Clinical, Pharmaceutical, Engineering, Technology and Management Fields.
Meet Inspiring Speakers and Experts at our 3000+ Global Conferenceseries Events with over 600+ Conferences, 1200+ Symposiums and 1200+ Workshops on
Medical, Pharma, Engineering, Science, Technology and Business

Antimicrobial Properties of Various Non-Antibiotic Drugs against Microorganisms

Sadik Kalayci*

Department of Genetics and Bioengineering, Faculty of Engineering, Yeditepe University, Turkey

Corresponding Author:
Sadik Kalayci
Genetics and Bioengineering Department
Faculty of Engineering Yeditepe University Kayisdagi, Istanbul, Turkey
Tel: +90 (216) 578 0619
Fax: +90 (216) 578 0829
E-mail: [email protected]

Received Date: July 01, 2016; Accepted Date: July 02, 2016; Published Date: July 05, 2016

Citation: Kalayci S (2016) Antimicrobial Properties of Various Non-Antibiotic Drugs against Microorganisms. J Bioanal Biomed 8: e142. doi:10.4172/1948-593X.1000e142

Copyright: © 2016 Kalayci S. This is an open-access article distributed under the terms of the Creative Commons Attribution License, which permits unrestricted use, distribution, and reproduction in any medium, provided the original author and source are credited.

Visit for more related articles at Journal of Bioanalysis & Biomedicine

Editorial

Antibiotics and antimicrobial chemotherapeutics exist in large numbers in today’s pharmaceutical market. Despite their use is becoming increasingly restricted. The reason behind such a rapid decline is largely attributed to the development of drug resistance among microorganisms. Such a phenomenon is coupled by the toxicity possessed by many antimicrobials. Multiple drug resistance among highly infective microorganisms generates a major obstacle to clinical applications in recent years. As development of a new broad range antimicrobial agent is difficult and takes several years, increasing the activity of existing antibiotics would be a future solution to this challenge. However, there is a search for newer antimicrobial agents that can overcome these drawbacks. Studies in this line have exposed the fact that several compounds, belonging to various pharmacological classes, possess moderate to powerful antibacterial activity.

There are some synthetic or natural medicinal compounds, referred as non-antibiotics, which are effective against microbial metabolism [1]. A number of non-antibiotic drugs including non-steroidal antiinflammatory drugs, calcium channel blockers and antidepressants have been reported to display biocidal or biostatic activity [2]. In addition, recent studies showed that some repellent molecules such as Picaridin and DEET, which are spread to the body of people and clothes to remove some arthropods (mosquitoes, lice, ticks, etc.), have also antimicrobial property [3].

These non-antibiotic drugs act in different manners on microbial growth. They may have direct antimicrobial activity (antimicrobial nonantibiotics), increase the efficiency of an antibiotic as given together (helper compounds), or change the pathogenicity of microorganisms or activity on the physiology such as modulating macrophage activity [4]. For example, antidepressants such as Sertraline, Paroxetine, and Fluoxetine have been shown to decrease minimum inhibition concentration (MIC) levels of several antibiotics mainly by inhibiting efflux pump activity [5-8]. Beyond acting synergistically, some psychotic drugs exhibit antimicrobial characteristics. They have been effective against gram negative and positive bacteria [2,9,10], yeast [11], fungi [12], and protozoa [13].

The main limiting factor of non-antibiotic drugs to display their antimicrobial characteristics in mammalian system is that the maximum serum level remains (approx. 1mg/L) lower than the concentration required inhibiting microbial growth [2]. However, these levels might be sufficient to modify microbial metabolism and act synergistically with certain antibiotics [14,15]. For example, it has been claimed that 0.75mg/L sertraline, lower than the tissue concentration in vivo, resulted in lack of hyphal transformation and decrease in virulence for Candida spp. [16].

Given the increasing incidence of infections and the limited efficacy of currently available antimicrobial agents, new approaches are needed. A broad spectrum of drugs produced by microorganisms might be investigated for their antimicrobial activity. On the other hand, the currently published information describes in vitro activity and in vivo efficacy in animals. There is very limited clinical information that indicates clinically relevant activity of non-antibiotics compounds in humans. In addition, there is a need to take pharmacodynamics into account in vivo. On the basis of this information, new approaches to the infection can be designed.

References

Select your language of interest to view the total content in your interested language
Post your comment

Share This Article

Article Usage

  • Total views: 8711
  • [From(publication date):
    August-2016 - Oct 19, 2017]
  • Breakdown by view type
  • HTML page views : 8608
  • PDF downloads :103
 

Post your comment

captcha   Reload  Can't read the image? click here to refresh

Peer Reviewed Journals
 
Make the best use of Scientific Research and information from our 700 + peer reviewed, Open Access Journals
International Conferences 2017-18
 
Meet Inspiring Speakers and Experts at our 3000+ Global Annual Meetings

Contact Us

Agri, Food, Aqua and Veterinary Science Journals

Dr. Krish

[email protected]

1-702-714-7001 Extn: 9040

Clinical and Biochemistry Journals

Datta A

[email protected]

1-702-714-7001Extn: 9037

Business & Management Journals

Ronald

[email protected]

1-702-714-7001Extn: 9042

Chemical Engineering and Chemistry Journals

Gabriel Shaw

[email protected]

1-702-714-7001 Extn: 9040

Earth & Environmental Sciences

Katie Wilson

[email protected]

1-702-714-7001Extn: 9042

Engineering Journals

James Franklin

[email protected]

1-702-714-7001Extn: 9042

General Science and Health care Journals

Andrea Jason

[email protected]

1-702-714-7001Extn: 9043

Genetics and Molecular Biology Journals

Anna Melissa

[email protected]

1-702-714-7001 Extn: 9006

Immunology & Microbiology Journals

David Gorantl

[email protected]

1-702-714-7001Extn: 9014

Informatics Journals

Stephanie Skinner

[email protected]

1-702-714-7001Extn: 9039

Material Sciences Journals

Rachle Green

[email protected]

1-702-714-7001Extn: 9039

Mathematics and Physics Journals

Jim Willison

[email protected]micsonline.com

1-702-714-7001 Extn: 9042

Medical Journals

Nimmi Anna

[email protected]

1-702-714-7001 Extn: 9038

Neuroscience & Psychology Journals

Nathan T

[email protected]

1-702-714-7001Extn: 9041

Pharmaceutical Sciences Journals

John Behannon

[email protected]

1-702-714-7001Extn: 9007

Social & Political Science Journals

Steve Harry

[email protected]

1-702-714-7001 Extn: 9042

 
© 2008-2017 OMICS International - Open Access Publisher. Best viewed in Mozilla Firefox | Google Chrome | Above IE 7.0 version
adwords